Reta pregnancy safety is unclear: retatrutide is not approved for human use, and animal studies suggest fetal risk. Learn what to do if you're pregnant.
Reta (retatrutide) is not safe or recommended during pregnancy. There are no human studies of retatrutide in pregnant women, and animal research shows fetal harm. If you are pregnant or trying to conceive, do not use reta and speak with your healthcare provider about safer options.
What Is Reta (Retatrutide)?
Retatrutide, often shortened to “reta,” is an investigational drug that acts on three hormone receptors: GLP-1, GIP, and glucagon. It is being studied for obesity and type 2 diabetes, but it is not FDA-approved for any use. Reta is not legally available by prescription in the United States.
Because reta is still in clinical trials, safety information is limited. Pregnancy is almost always an exclusion criterion for these trials, so researchers have no direct data on reta pregnancy outcomes. Retatrutide is given as a weekly injection in clinical trials, and it stays in the body for weeks, so it cannot be quickly cleared if you become pregnant.
Why Reta Pregnancy Is a Concern
GLP-1-based medications can affect appetite, blood sugar, and digestion. These effects may interfere with fetal development, especially in the first trimester. Animal studies of retatrutide have shown increased risks of fetal malformations and lower fetal weight at doses similar to those used in humans.
Human data for similar drugs are also limited. For example, semaglutide pregnancy research has not shown a clear pattern of birth defects, but the FDA still recommends stopping semaglutide at least two months before a planned pregnancy. The same caution applies to reta.
Some people ask about glutathione and pregnancy for antioxidant support. Glutathione is generally considered safe in food amounts, but it is not a substitute for avoiding reta. No supplement can cancel out the unknown risks of an investigational weight-loss drug.
What Research Shows About Reta and Pregnancy
In animal studies, retatrutide caused embryo-fetal toxicity when given to pregnant rats and rabbits. These findings do not prove that reta causes birth defects in humans, but they are a serious warning sign. The FDA typically classifies such drugs as contraindicated in pregnancy unless benefits clearly outweigh risks.
Other research peptides are sometimes discussed in bodybuilding and biohacking circles. Stacks like mots-c and reta have no pregnancy safety data at all. Similarly, reta cagri blend side effects are not studied in pregnant women, and the combination is not approved for human use.
Here is how reta compares with other common weight-loss and metabolic drugs for pregnancy.
| Compound | FDA Status | Pregnancy Recommendation | Human Pregnancy Data |
|---|---|---|---|
| Retatrutide (reta) | Not approved | Avoid; stop before conception | None |
| Semaglutide (Ozempic, Wegovy) | Approved for diabetes/obesity | Stop at least 2 months before pregnancy | Limited, no clear birth defect pattern |
| Tirzepatide (Mounjaro, Zepbound) | Approved for diabetes/obesity | Stop before pregnancy; not recommended | Limited |
| Insulin | Approved | Safe and preferred for diabetes in pregnancy | Extensive |
What to Do If You're Pregnant and Using Reta
If you are pregnant and taking reta, stop the drug immediately and contact your obstetrician. Do not wait for your next appointment. Your doctor can check the pregnancy and discuss any needed monitoring. They may order extra ultrasound monitoring to check fetal growth, since there is no antidote or reversal agent for reta.
If you are planning a pregnancy, stop reta at least two months before trying to conceive. This matches the advice for other GLP-1 drugs. Do not restart reta until you have finished breastfeeding and your doctor says it is safe.
For diabetes or weight management during pregnancy, insulin is often the safest medication. Nutritional counseling and medically supervised exercise are also helpful. Always talk to your healthcare provider before starting or stopping any drug or supplement.
Other Peptides and Pregnancy: What to Know
Peptides like thymosin alpha 1 are sometimes promoted for immune support. Little is known about thymosin alpha 1 injection uses in pregnancy, and pregnant women should avoid them unless a specialist prescribes them for a specific condition.
No research peptide—including BPC-157, MOTS-c, or cagrilintide—has been proven safe in pregnancy. The only reliable approach is to avoid all non-essential drugs and supplements while pregnant or trying to conceive. Always check with a maternal-fetal medicine specialist if you have a chronic condition that requires medication.
The Bottom Line
Reta pregnancy is a clear no-go. Retatrutide is not approved, not studied in pregnant humans, and linked to fetal harm in animals. If you are pregnant or planning to become pregnant, do not use reta. Consult your healthcare provider for safe alternatives.
Frequently Asked Questions
Can I take reta while pregnant?
No. Retatrutide is not FDA-approved, has no human pregnancy data, and animal studies show fetal harm. Stop reta immediately and call your doctor if you are pregnant.
How long before pregnancy should I stop reta?
Health guidelines recommend stopping GLP-1 drugs like reta at least two months before trying to conceive. Your doctor may advise a longer washout period based on your individual health.
Is reta safe while breastfeeding?
There is no human data on reta during breastfeeding, and it may pass into breast milk. Avoid reta while nursing and use safer alternatives under medical supervision.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.